Aspen Pharmacare Australia Pty Ltd.
🇦🇺Australia
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
533
TGA:513
NMPA:18
SFDA:2
Drug Approvals
Ropivacaine Hydrochloride Injection
- Product Name
- 耐乐品
- Approval Number
- 国药准字HJ20140766
- Approval Date
- Dec 31, 2024
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 耐乐品
- Approval Number
- 国药准字HJ20140763
- Approval Date
- Dec 31, 2024
NMPA
Ropivacaine Hydrochloride Injection
- Product Name
- 耐乐品
- Approval Number
- 国药准字HJ20140764
- Approval Date
- Dec 31, 2024
NMPA
Lidocaine and Prilocaine Cream
- Product Name
- 恩纳
- Approval Number
- 国药准字HJ20100154
- Approval Date
- Sep 9, 2024
NMPA
Cisatracurium Besylate Injection
- Product Name
- 赛机宁
- Approval Number
- 国药准字HJ20181159
- Approval Date
- Jun 11, 2021
NMPA
Cisatracurium Besylate Injection
- Product Name
- 赛机宁
- Approval Number
- 国药准字HJ20181157
- Approval Date
- Jun 11, 2021
NMPA
Cisatracurium Besylate Injection
- Product Name
- 赛机宁
- Approval Number
- 国药准字HJ20181158
- Approval Date
- Jun 11, 2021
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found